Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nasal delivery
Pharma
ARS hits major setback in bid to launch epinephrine newcomer
The company had already aligned with the FDA in August on final labeling and a post-marketing study plan. Now, it's appealing the FDA rejection.
Fraiser Kansteiner
Sep 20, 2023 10:31am
Orexo seeks approval of nasal high-dose opioid rescue medicine
Feb 7, 2023 8:40am
Aptar creates metal-free nasal spray pump to boost recyclability
Jan 31, 2023 11:59am
Nasal delivery gets antibody to rodent brains to treat stroke
Jan 24, 2023 6:40am
Satsuma peels off fresh strip of long-term migraine study data
Sep 26, 2022 10:27am
RIGImmune subsumes Subintro in nasal drug delivery buyout
Sep 19, 2022 6:55am